Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology

A persistent digestive disorder known as ulcerative colitis (UC) is characterized by a high rate of recurrence and a difficult road to full recovery. An herbal treatment with a long history of use in conventional Chinese medicine, Artemisia argyi, has shown encouraging results in preventing the retu...

Full description

Bibliographic Details
Main Authors: Menghe Li, Jianghao Liu, Caiwenjie La, Tao Liu, Zibo Zhao, Zui Wang, Minghui Dai, Jiming Chen, Zhe Ren, Cuifang Ye, Yifei Wang
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Arabian Journal of Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878535223005129
_version_ 1797776694588735488
author Menghe Li
Jianghao Liu
Caiwenjie La
Tao Liu
Zibo Zhao
Zui Wang
Minghui Dai
Jiming Chen
Zhe Ren
Cuifang Ye
Yifei Wang
author_facet Menghe Li
Jianghao Liu
Caiwenjie La
Tao Liu
Zibo Zhao
Zui Wang
Minghui Dai
Jiming Chen
Zhe Ren
Cuifang Ye
Yifei Wang
author_sort Menghe Li
collection DOAJ
description A persistent digestive disorder known as ulcerative colitis (UC) is characterized by a high rate of recurrence and a difficult road to full recovery. An herbal treatment with a long history of use in conventional Chinese medicine, Artemisia argyi, has shown encouraging results in preventing the return of clinical UC. We carried out an experiment to isolate and identify the small molecules in Artemisia argyi to investigate the chemical makeup of the therapeutic UC in this plant. Following an activity screen, we discovered that 3β-ethoxytanapartholide (ETP) had significantly greater anti-inflammatory action than the medicine we had chosen as a positive control, dexamethasone, and this is the first report of ETP in terms of biological activity. Systematic network pharmacological analysis confirmed that ETP acted on multiple targets during the pathogenesis of UC. These targets regulate a variety of UC-related signaling pathways, including but not limited to TNF, IL-17, and Ca2+ signaling. Molecular dynamics simulations and MM-PBSA results showed that ETP was able to form stable complexes with five targets, MMP1, MMP9, MUC1, S1PR1 and MMP12. The current work has previously shown the unknown anti-inflammatory ability of ETP and discovered that ETP can modulate various pathways throughout the development of UC to produce therapeutic advantages. These ground-breaking results highlight the urgent need for more analysis and development of ETP as a potential treatment plan for UC.
first_indexed 2024-03-12T22:53:33Z
format Article
id doaj.art-f999184de24c4e80b6954e8c2f888319
institution Directory Open Access Journal
issn 1878-5352
language English
last_indexed 2024-03-12T22:53:33Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Arabian Journal of Chemistry
spelling doaj.art-f999184de24c4e80b6954e8c2f8883192023-07-20T04:38:00ZengElsevierArabian Journal of Chemistry1878-53522023-09-01169105050Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacologyMenghe Li0Jianghao Liu1Caiwenjie La2Tao Liu3Zibo Zhao4Zui Wang5Minghui Dai6Jiming Chen7Zhe Ren8Cuifang Ye9Yifei Wang10Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, ChinaDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, ChinaDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, ChinaDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, ChinaDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, ChinaGuangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, ChinaGuangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, ChinaDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, China; Corresponding authors at: Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China.Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, China; GuangZhou (Jinan) Biomedical Research and Development Center Co. Ltd, Guangzhou, China; Key Laboratory of Innovative Technology Research on Natural Products and Cosmetics Raw Materials, Guangzhou, China; National Engineering Research Center for Modernization of Traditional Chinese Medicine- Artemisia Argyi Branch Center, Guangzhou, China; Corresponding authors at: Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China.A persistent digestive disorder known as ulcerative colitis (UC) is characterized by a high rate of recurrence and a difficult road to full recovery. An herbal treatment with a long history of use in conventional Chinese medicine, Artemisia argyi, has shown encouraging results in preventing the return of clinical UC. We carried out an experiment to isolate and identify the small molecules in Artemisia argyi to investigate the chemical makeup of the therapeutic UC in this plant. Following an activity screen, we discovered that 3β-ethoxytanapartholide (ETP) had significantly greater anti-inflammatory action than the medicine we had chosen as a positive control, dexamethasone, and this is the first report of ETP in terms of biological activity. Systematic network pharmacological analysis confirmed that ETP acted on multiple targets during the pathogenesis of UC. These targets regulate a variety of UC-related signaling pathways, including but not limited to TNF, IL-17, and Ca2+ signaling. Molecular dynamics simulations and MM-PBSA results showed that ETP was able to form stable complexes with five targets, MMP1, MMP9, MUC1, S1PR1 and MMP12. The current work has previously shown the unknown anti-inflammatory ability of ETP and discovered that ETP can modulate various pathways throughout the development of UC to produce therapeutic advantages. These ground-breaking results highlight the urgent need for more analysis and development of ETP as a potential treatment plan for UC.http://www.sciencedirect.com/science/article/pii/S1878535223005129Artemisia argyiNatural products3β-ethoxytanapartholideNetwork pharmacology
spellingShingle Menghe Li
Jianghao Liu
Caiwenjie La
Tao Liu
Zibo Zhao
Zui Wang
Minghui Dai
Jiming Chen
Zhe Ren
Cuifang Ye
Yifei Wang
Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology
Arabian Journal of Chemistry
Artemisia argyi
Natural products
3β-ethoxytanapartholide
Network pharmacology
title Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology
title_full Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology
title_fullStr Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology
title_full_unstemmed Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology
title_short Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology
title_sort exploring the mechanism of artemisia argyi chemical composition for ulcerative colitis based on network pharmacology
topic Artemisia argyi
Natural products
3β-ethoxytanapartholide
Network pharmacology
url http://www.sciencedirect.com/science/article/pii/S1878535223005129
work_keys_str_mv AT mengheli exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT jianghaoliu exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT caiwenjiela exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT taoliu exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT zibozhao exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT zuiwang exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT minghuidai exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT jimingchen exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT zheren exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT cuifangye exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology
AT yifeiwang exploringthemechanismofartemisiaargyichemicalcompositionforulcerativecolitisbasedonnetworkpharmacology